日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy

一项针对杜氏肌营养不良症的他达拉非3期随机安慰剂对照试验

Victor, Ronald G; Sweeney, H Lee; Finkel, Richard; McDonald, Craig M; Byrne, Barry; Eagle, Michelle; Goemans, Nathalie; Vandenborne, Krista; Dubrovsky, Alberto L; Topaloglu, Haluk; Miceli, M Carrie; Furlong, Pat; Landry, John; Elashoff, Robert; Cox, David

Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.

FHL1基因突变引起的还原体肌病的临床、组织学和遗传学特征

Schessl Joachim, Taratuto Ana L, Sewry Caroline, Battini Roberta, Chin Steven S, Maiti Baijayanta, Dubrovsky Alberto L, Erro Marcela G, Espada Graciela, Robertella Monica, Saccoliti Maria, Olmos Patricia, Bridges Leslie R, Standring Peter, Hu Ying, Zou Yaqun, Swoboda Kathryn J, Scavina Mena, Goebel Hans-Hilmar, Mitchell Christina A, Flanigan Kevin M, Muntoni Francesco, Bönnemann Carsten G